Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules… Read more
Inner Mongolia Furui Med Sci (300049) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.034x
Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has a cash flow conversion efficiency ratio of 0.034x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥78.76 Million) by net assets (CN¥2.35 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Inner Mongolia Furui Med Sci - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Inner Mongolia Furui Med Sci's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Inner Mongolia Furui Med Sci Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shift4 Payments Inc
NYSE:FOUR
|
0.077x |
|
Heilongjiang Agriculture Co Ltd
SHG:600598
|
-0.088x |
|
Innoviva Inc
NASDAQ:INVA
|
0.046x |
|
Sanbo Hospital Management Group Ltd. A
SHE:301293
|
N/A |
|
Terravest Capital Inc
TO:TVK
|
0.038x |
|
CSPC Innovation Pharmaceutical Co Ltd Class A
SHE:300765
|
-0.237x |
|
China Great Wall Securities Co Ltd Class A
SHE:002939
|
0.040x |
|
ADDLIFE AB B
F:1AD1
|
N/A |
Annual Cash Flow Conversion Efficiency for Inner Mongolia Furui Med Sci (2006–2024)
The table below shows the annual cash flow conversion efficiency of Inner Mongolia Furui Med Sci from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.13 Billion | CN¥221.41 Million | 0.104x | -36.95% |
| 2023-12-31 | CN¥1.85 Billion | CN¥304.89 Million | 0.165x | +59.04% |
| 2022-12-31 | CN¥1.83 Billion | CN¥189.46 Million | 0.104x | -10.05% |
| 2021-12-31 | CN¥1.81 Billion | CN¥208.31 Million | 0.115x | -6.88% |
| 2020-12-31 | CN¥1.62 Billion | CN¥200.15 Million | 0.124x | -24.98% |
| 2019-12-31 | CN¥1.55 Billion | CN¥256.23 Million | 0.165x | +218.76% |
| 2018-12-31 | CN¥1.51 Billion | CN¥78.35 Million | 0.052x | -20.68% |
| 2017-12-31 | CN¥1.93 Billion | CN¥126.16 Million | 0.065x | -19.90% |
| 2016-12-31 | CN¥1.83 Billion | CN¥148.84 Million | 0.082x | -14.91% |
| 2015-12-31 | CN¥1.65 Billion | CN¥158.16 Million | 0.096x | +72.35% |
| 2014-12-31 | CN¥915.10 Million | CN¥50.88 Million | 0.056x | +47.66% |
| 2013-12-31 | CN¥748.53 Million | CN¥28.18 Million | 0.038x | -67.84% |
| 2012-12-31 | CN¥733.64 Million | CN¥85.88 Million | 0.117x | +8.72% |
| 2011-12-31 | CN¥703.52 Million | CN¥75.75 Million | 0.108x | +50.45% |
| 2010-12-31 | CN¥687.42 Million | CN¥49.20 Million | 0.072x | +637.68% |
| 2009-12-31 | CN¥157.46 Million | CN¥-2.10 Million | -0.013x | -105.09% |
| 2008-12-31 | CN¥139.52 Million | CN¥36.47 Million | 0.261x | +87.15% |
| 2007-12-31 | CN¥127.76 Million | CN¥17.85 Million | 0.140x | -64.88% |
| 2006-12-31 | CN¥124.50 Million | CN¥49.52 Million | 0.398x | -- |